Praia, May 22 (Inforpress) – Health authorities will review the current protocol that suggests the use of hydroxychloroquine in the treatment of infected with COVID-19, so that, according to scientific evidence, they can make a decision regarding the treatment that aim to “save lives”.
According to information provided to the press by the coordinator of the technical scientific sub-commission on the prevention and control of diseases, Noel Barreto, Cabo Verde uses hydroxychroloquine, as it is a drug very similar to chloroquine, but with less adverse effects, taking into account the experience of countries like China and Germany.
“This medicine is one of the alternatives, according to the medical evaluation and the team discussion of the serious cases, the working group, as long as the patient can benefit from its use”, summarised Jorge Noel Barreto.
In a press conference, the infeciologist said that given the most recent evidence that chloroquine may not be as effective, the protocol being used will be reviewed. Chloroquine is a drug used in the treatment and prophylaxis of malaria in regions where this disease is susceptible to its effect.
SR / JMV / HVF